Prediabetes / Type 2 Diabetes
16
4
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.4% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (16)
Blood-based sEV Proteins for Early Detection of 2 Diabetes
CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial
Effects of Exercise Snacks on Clinical and Health Outcomes
HbA1c Screening in Dental Care and Primary Care Referral in Patients With Advanced Periodontitis
Effects of Exercise Prediabetic Individuals
Health Assessment of Low Glycaemic Index - High Protein Rice to Enhance Glycemic Control Through Nutrition
Diabetes Prevention in Hispanic Adults Using Constant Glucose Monitors
Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes
An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 Diabetes